Sentra AM® and Sentra PM® for Post-traumatic Stress Disorder (PTSD) and Gulf War Fibromyalgia (GWF)
NCT01437891 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2012-02-06
Summary
An open-label clinical outcomes study to determine the safety and efficacy of Sentra AM® and Sentra PM® for post-traumatic stress disorder (PTSD) and Gulf War fibromyalgia (GWF).
Conditions
- Post-traumatic Stress Disorder
- Persian Gulf Syndrome
Sponsors & Collaborators
-
Stephanie Pavlik
lead INDUSTRY
Principal Investigators
-
William Shell, MD · Targeted Medical Pharma, Inc.
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-09-30
- Primary Completion
- 2012-01-31
- Completion
- 2012-01-31
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of GSK561679 in Women With Post-Traumatic Stress Disorder
NCT01018992 ·Status: COMPLETED ·Phase: PHASE2
-
Neurofeedback for Post-Traumatic Stress Disorder
NCT05123690 ·Status: RECRUITING ·Phase: NA
-
The Use of Noninvasive Brain Stimulation in Post-traumatic Stress Disorder
NCT02542709 ·Status: UNKNOWN ·Phase: NA
-
The Effects of Very Brief Exposure on PTSD in U.S. Combat Veterans
NCT06218381 ·Status: RECRUITING ·Phase: NA
-
Substance P Antagonist in the Treatment of Posttraumatic Stress Disorder
NCT00383786 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Military Service and Family Members for Post Concussive and Posttraumatic Stress Symptoms
NCT03191357 ·Status: COMPLETED
-
Neuromodulation for Post-Traumatic Stress Disorder
NCT02377089 ·Status: COMPLETED ·Phase: NA
-
Software as a Medical Device for the Treatment of Patients With PTSD
NCT06589505 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Follow-up of Psychological and Neurocognitive Gulf War Outcome: Relation to Stress
NCT00018707 ·Status: COMPLETED
-
INTRuST Structured Assessment For Evaluation of TBI (SAFE-TBI)
NCT01554891 ·Status: COMPLETED
-
Effectiveness of Sana Treatment in Post-Traumatic Stress Disorder (PTSD)
NCT05319405 ·Status: COMPLETED ·Phase: NA
-
3MDR to Treat PTSD With mTBI (3MDR)
NCT03796936 ·Status: COMPLETED ·Phase: PHASE2
-
Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD
NCT03932773 ·Status: RECRUITING ·Phase: NA
-
Predictors of Treatment Response to Fluoxetine in PTSD Following a Recent History of War Zone Stress Exposure
NCT00633685 ·Status: UNKNOWN ·Phase: PHASE4
-
A Self-Management Program for Completers of Trauma-Focused Therapy for PTSD
NCT03225859 ·Status: COMPLETED ·Phase: NA
-
Low -vs- High-Frequency Repetitive TMS of the Right Dorsolateral Prefrontal Cortex in PTSD
NCT02369614 ·Status: TERMINATED ·Phase: NA
-
Effects of an Alternative Treatment for Military Sexual Trauma on PTSD Symptoms, Neurosteroids and Brain Function
NCT00374738 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial to Preliminarily Assess the Safety and Feasibility of SAT-014, a Software for Alleviating Symptoms of Trauma and Stress-related Disorders
NCT06439407 ·Status: COMPLETED ·Phase: NA
-
Effects of Stellate Ganglion Block in Post-traumatic Stress Disorder
NCT05391971 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Investigation of the Freespira Breathing System in the Treatment of Post Traumatic Stress Disorder (PTSD)
NCT03039231 ·Status: COMPLETED ·Phase: NA
-
Effectiveness and Acceptability of Stellate Ganglion Block for Posttraumatic Stress Disorder Symptoms - Acceptability
NCT03302312 ·Status: COMPLETED
-
Trial to Evaluate Efficacy of Magnetic Resonant Therapy (MRT) in PTSD
NCT02268084 ·Status: COMPLETED ·Phase: NA
-
Pivotal Trial of SAT-014 for Trauma and Stressor-Related Disorder Symptoms
NCT06734858 ·Status: COMPLETED ·Phase: NA
-
Quetiapine Augmentation for Treatment-resistant PTSD
NCT00292370 ·Status: COMPLETED ·Phase: PHASE4
-
Combined Mirtazapine and SSRI Treatment of PTSD: A Placebo-Controlled Trial
NCT01178671 ·Status: COMPLETED ·Phase: PHASE4